Advertisement
UK markets close in 7 hours 27 minutes
  • FTSE 100

    7,830.63
    -46.42 (-0.59%)
     
  • FTSE 250

    19,274.26
    -176.41 (-0.91%)
     
  • AIM

    740.91
    -4.38 (-0.59%)
     
  • GBP/EUR

    1.1681
    -0.0002 (-0.02%)
     
  • GBP/USD

    1.2445
    +0.0007 (+0.06%)
     
  • Bitcoin GBP

    51,952.23
    +2,742.89 (+5.57%)
     
  • CMC Crypto 200

    1,327.69
    +15.06 (+1.15%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CRUDE OIL

    83.66
    +0.93 (+1.12%)
     
  • GOLD FUTURES

    2,402.20
    +4.20 (+0.18%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,242.80
    -143.07 (-0.87%)
     
  • DAX

    17,664.16
    -173.24 (-0.97%)
     
  • CAC 40

    7,965.67
    -57.59 (-0.72%)
     

Rite Aid (RAD) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Rite Aid (RAD) closed at $13.94, marking a -0.21% move from the previous day. This change lagged the S&P 500's daily gain of 2.62%. At the same time, the Dow added 3.16%, and the tech-heavy Nasdaq gained 2.06%.

Wall Street will be looking for positivity from RAD as it approaches its next earnings report date. The company is expected to report EPS of -$0.54, down 285.71% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $5.60 billion, up 4.21% from the year-ago period.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.31 per share and revenue of $22.49 billion. These totals would mark changes of -306.67% and +2.54%, respectively, from last year.

Any recent changes to analyst estimates for RAD should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

ADVERTISEMENT

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. RAD is currently a Zacks Rank #4 (Sell).

The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 194, putting it in the bottom 24% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Rite Aid Corporation (RAD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research